Anti-inflammatory properties of cannabichromene.
D000818:Animals; D000893:Anti-Inflammatory Agents; D001241:Aspirin / Q000494:pharmacology; D001578:Benzopyrans / Q000494:pharmacology*; D002186:Cannabinoids / Q000494:pharmacology*; D004487:Edema / Q000188:drug therapy; D004910:Erythrocyte Membrane / Q000187:drug effects; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006358:Hot Temperature; D008297:Male; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats
D000893:Anti-Inflammatory Agents; D001578:Benzopyrans; D002186:Cannabinoids; D010653:Phenylbutazone; C010695:cannabichromene; D001241:Aspirin